MedPath

Antioxidant effects of crocin in patients undergoing angiography

Phase 3
Conditions
contrast induced acute kidney Injury.
Other acute kidney failure
N17.8
Registration Number
IRCT20200721048159N5
Lead Sponsor
Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

patient consent to enter to the study
being candidate for angiography
being over 18 years old
systolic pressure of greater than 90 mm Hg

Exclusion Criteria

patient's tendency to exit from the study
having Anaphylactic and anaphylactoid reactions during contrast media administration
consumption of common antioxidant medicines in less than one week before use of contrast media and angiography
consumption of nephrotoxic medicines (aminoglycosides, vancomycin and others) in less than one week before use of contrast media and angiography
unstable kidney status or need of kidney transplantation
impossibility of intravenous hydration for the patient
consumption of Warfarin
pregnancy and breastfeeding
history of hypersensitivity to saffron
history of hypersensitivity to contrast media
participate in other clinical trials that their results may confound this intervention at least for a 28 days period

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath